Equities

Vistin Pharma ASA

Vistin Pharma ASA

Actions
  • Price (NOK)27.60
  • Today's Change27.60 / --
  • Shares traded40.00
  • 1 Year change+24.89%
  • Beta--
Data delayed at least 20 minutes, as of Oct 17 2024 17:47 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of NOK
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
REVENUE AND GROSS PROFIT
Total revenue435288276
OPERATING EXPENSES
Cost of revenue total17713896
Selling, general and admin. expenses, total937973
Depreciation/amortization171211
Unusual expense(income)------
Other operating expenses, total806462
Total operating expense367294243
Operating income69(6.1)33
Other, net(0.11)(0.31)(0.04)
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes59(6.01)32
Provision for income taxes13(1.29)7.13
Net income after taxes46(4.72)25
Minority interest------
Net income before extra. Items46(4.72)25
Total extraordinary items------
Net income46(4.72)25
Inc.avail. to common excl. extra. Items46(4.72)25
Inc.avail. to common incl. extra. Items46(4.72)25
EPS RECONCILIATION
Basic/primary weighted average shares444444
Basic/primary eps excl. extra items1.03(0.11)0.56
Basic/primary eps incl. extra items1.03(0.11)0.56
Dilution adjustment------
Diluted weighted average shares444444
Diluted eps excl. extra items1.03(0.11)0.56
Diluted eps incl. extra items1.03(0.11)0.56
COMMON STOCK DIVIDENDS
DPS - common stock primary issue1.000.750
Gross dividend - common stock------
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental2.272.140.36
SUPPLEMENTAL INCOME
Depreciation, supplemental171211
Total special items------
NORMALISED INCOME
Normalized income before taxes59(6.01)32
Effect of special items on income taxes------
Income tax excluding impact of special items13(1.29)7.13
Normalized income after tax46(4.72)25
Normalized income avail. to common46(4.72)25
Basic normalized EPS1.03(0.11)0.56
Diluted normalized EPS1.03(0.11)0.56
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.